These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1370427)

  • 1. Ploidy analysis of epithelial ovarian cancers using image cytometry.
    Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
    Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.
    Ioakim-Liossi A; Karakitsos P; Aroni K; Delivelioti K; Fotiou V; Fotiou S; Kyrkou K
    Acta Cytol; 1997; 41(6):1714-8. PubMed ID: 9390130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
    Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
    Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
    Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
    Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ploidy as a prognostic factor in ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
    Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular DNA content and survival in advanced ovarian carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
    Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
    Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas.
    Aghmesheh M; Saxena A; Niknam F
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):135-41. PubMed ID: 25428229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma.
    Takes RP; Baatenburg de Jong RJ; van Blommestein R; Hermans J; van Krieken HH; Cornelisse CJ
    Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):1015-20. PubMed ID: 12450177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on DNA content in ploidy patterns of esophageal cancer].
    Rikitake H
    Nihon Geka Gakkai Zasshi; 1990 May; 91(5):564-74. PubMed ID: 2385220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with clinical staging and histologic grading.
    Hemmer J; Kreidler J
    Cancer; 1990 Jul; 66(2):317-20. PubMed ID: 2369714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.
    Rotmensch J; Atcher RW; Schwartz JL; Grdina DJ
    Gynecol Oncol; 1992 Jan; 44(1):10-2. PubMed ID: 1730415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
    Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
    Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.